The King Faisal and Davos of Healthcare Innovation Challenge, hosted by the King Faisal Specialist Hospital & Research Centre (KFSHRC), Cure, and C3 International, is a unique competition to identify groundbreaking technological solutions in eight (8) distinct healthcare areas that align with the KFSHRC Centres of Excellence.  

The Challenge is open to startups and entrepreneurs with MVPs (Minimum Viable Products) and aims to accelerate the growth and development of innovative healthcare solutions and bring new products to the market.  

Application Window: May 19 - June 30, 2025

When you engage with Cure, you advance health. Working together as a partner or a sponsor, you can incubate solutions, convene thought leaders, drive collaboration, and educate the next generation of innovators.

Cure believes in empowering diverse perspectives to forge new paths in life sciences innovation. Women in Science is the hallmark program of our Science to the Street initiative and is designed to remove the barriers that hinder life sciences innovation and commercial advancement.

The Cure Xchange Challenge focuses on driving innovations that collaboratively span sectors, disciplines and geographies to solve for a specific healthcare need. The contest is open to individuals and teams with early stage concepts, prototypes or pilots that will transform our health.

The XSeed Award provides critical funding to translate scientific discoveries into commercially successful drug therapies. The 2024 XSeed awards will provide two teams up to $250,000 for New York City minority- and women-led life science and healthcare startups working on novel drug development projects. Additionally, the winning teams will join the ecosystem of Cure.®, and teams will receive peer-learning and office hours with investors, entrepreneurs and business experts.